Trials / Completed
CompletedNCT01124396
DSP-3025 A Phase 1 Study of Healthy Male Volunteers
A Double-blind, Placebo-controlled, Randomised Study to Investigate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Repeated Weekly Doses of DSP-3025 Administered Intranasally to Healthy Male Volunteers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- Sumitomo Pharma Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
Investigate safety/tolerability after repeated weekly doses intranasal administration of DSP-3025 comparator placebo to healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DSP-3025 | |
| DRUG | Placebo |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-08-01
- Completion
- 2012-04-01
- First posted
- 2010-05-17
- Last updated
- 2022-04-12
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01124396. Inclusion in this directory is not an endorsement.